| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |